Literature DB >> 9736721

Very late DNA replication in the human cell cycle.

R J Widrow1, R S Hansen, H Kawame, S M Gartler, C D Laird.   

Abstract

G2 was defined originally as the temporal gap between the termination of DNA replication and the beginning of mitosis. In human cells, the G2 period was estimated to be 3-4 h. However, the absence of replicative DNA synthesis during this period designated G2 has never been shown conclusively. In this report, we show that, at some autosomal and X linked loci, programmed DNA replication continues within 90 min of mitosis. Furthermore, the major accumulation of cyclin B1, a cell-cycle marker that is usually ascribed to G2, overlaps extensively with very late DNA replication. We conclude that the G2 period is much shorter than previously thought and may, in some cells, be nonexistent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736721      PMCID: PMC21627          DOI: 10.1073/pnas.95.19.11246

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Separation of cells at different times within G2 and mitosis by cyclin B1 flow cytometry.

Authors:  R J Widrow; P S Rabinovitch; K Cho; C D Laird
Journal:  Cytometry       Date:  1997-03-01

2.  Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2.

Authors:  J Pines; T Hunter
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

3.  DNA repair in UV-irradiated heteroploid cells at different phases of the cell cycle.

Authors:  E Giulotto; A Mottura; L De Carli; F Nuzzo
Journal:  Exp Cell Res       Date:  1978-05       Impact factor: 3.905

Review 4.  Repetitive synchronization of human lymphoblast cultures with excess thymidine.

Authors:  H R Zielke; J W Littlefield
Journal:  Methods Cell Biol       Date:  1974       Impact factor: 1.441

Review 5.  The cell cycle of mammalian cells.

Authors:  R Baserga; F Wiebel
Journal:  Int Rev Exp Pathol       Date:  1969

6.  Late DNA replication pattern in human haemopoietic cells. A comparative investigation using a high resolution quantitative autoradiography.

Authors:  F Gavosto; L Pegoraro; P Masera; G Rovera
Journal:  Exp Cell Res       Date:  1968-02       Impact factor: 3.905

7.  Replication timing of genes and middle repetitive sequences.

Authors:  M A Goldman; G P Holmquist; M C Gray; L A Caston; A Nag
Journal:  Science       Date:  1984-05-18       Impact factor: 47.728

8.  A variable domain of delayed replication in FRAXA fragile X chromosomes: X inactivation-like spread of late replication.

Authors:  R S Hansen; T K Canfield; A D Fjeld; S Mumm; C D Laird; S M Gartler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Radiation-stimulated DNA synthesis in cultured mammalian cells.

Authors:  R E Rasmussen; R B Painter
Journal:  J Cell Biol       Date:  1966-04       Impact factor: 10.539

10.  Incorporation of tritium-labeled thymidine and lysine into chromosomes of cultured human leukocytes.

Authors:  M D Cave
Journal:  J Cell Biol       Date:  1966-05       Impact factor: 10.539

View more
  23 in total

1.  Analysis of replication timing at the FRA10B and FRA16B fragile site loci.

Authors:  O Handt; E Baker; S Dayan; S M Gartler; E Woollatt; R I Richards; R S Hansen
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

2.  Long-distance control of origin choice and replication timing in the human beta-globin locus are independent of the locus control region.

Authors:  D M Cimbora; D Schübeler; A Reik; J Hamilton; C Francastel; E M Epner; M Groudine
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription.

Authors:  Sandie Tuduri; Laure Crabbé; Chiara Conti; Hélène Tourrière; Heidi Holtgreve-Grez; Anna Jauch; Véronique Pantesco; John De Vos; Aubin Thomas; Charles Theillet; Yves Pommier; Jamal Tazi; Arnaud Coquelle; Philippe Pasero
Journal:  Nat Cell Biol       Date:  2009-10-18       Impact factor: 28.824

4.  SIR2 suppresses replication gaps and genome instability by balancing replication between repetitive and unique sequences.

Authors:  Eric J Foss; Uyen Lao; Emily Dalrymple; Robin L Adrianse; Taylor Loe; Antonio Bedalov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

Review 5.  Interplay between genetic and epigenetic factors governs common fragile site instability in cancer.

Authors:  Efrat Ozeri-Galai; Michal Tur-Sinai; Assaf C Bester; Batsheva Kerem
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

Review 6.  Break-induced replication links microsatellite expansion to complex genome rearrangements.

Authors:  Michael Leffak
Journal:  Bioessays       Date:  2017-06-16       Impact factor: 4.345

7.  G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome.

Authors:  Eric J Foss; Uyen Lao; Antonio Bedalov
Journal:  J Vis Exp       Date:  2018-03-22       Impact factor: 1.355

8.  Barrier-to-Autointegration Factor influences specific histone modifications.

Authors:  Rocío Montes de Oca; Paul R Andreassen; Katherine L Wilson
Journal:  Nucleus       Date:  2011-11-01       Impact factor: 4.197

9.  Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes.

Authors:  Benjamin A Hilton; Ji Liu; Brian M Cartwright; Yiyong Liu; Maya Breitman; Youjie Wang; Rowdy Jones; Hui Tang; Antonio Rusinol; Phillip R Musich; Yue Zou
Journal:  FASEB J       Date:  2017-05-17       Impact factor: 5.191

10.  Onset and sequence of RBA-band replication on the inactive X-chromosomes of cattle (Bos taurus L.), river buffalo (Bubalus bubalis L.) and goat (Capra hircus L.).

Authors:  D Di Berardino; G Coppola; C Verdoliva; G F Coppola; L Ramunno; G Enne; G P Di Meo; L Iannuzzi
Journal:  Chromosome Res       Date:  2002       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.